A hybrid discrete-continuum modelling approach for the interactions of the immune system with oncolytic viral infections (2404.06459v1)

Abstract: Oncolytic virotherapy, utilizing genetically modified viruses to combat cancer and trigger anti-cancer immune responses, has garnered significant attention in recent years. In our previous work arXiv:2305.12386, we developed a stochastic agent-based model elucidating the spatial dynamics of infected and uninfected cells within solid tumours. Building upon this foundation, we present a novel stochastic agent-based model to describe the intricate interplay between the virus and the immune system; the agents' dynamics are coupled with a balance equation for the concentration of the chemoattractant that guides the movement of immune cells. We formally derive the continuum limit of the model and carry out a systematic quantitative comparison between this system of PDEs and the individual-based model in two spatial dimensions. Furthermore, we describe the traveling waves of the three populations, with the uninfected proliferative cells trying to escape from the infected cells while immune cells infiltrate the tumour. Simulations show a good agreement between agent-based approaches and numerical results for the continuum model. Some parameter ranges give rise to oscillations of cell number in both models, in line with the behaviour of the corresponding nonspatial model, which presents Hopf bifurcations. Nevertheless, in some situations the behaviours of the two models may differ significantly, suggesting that stochasticity plays a key role in the dynamics. Our results highlight that a too rapid immune response, before the infection is well-established, appears to decrease the efficacy of the therapy and thus some care is needed when oncolytic virotherapy is combined with immunotherapy. This further suggests the importance of clinically improving the modulation of the immune response according to the tumour's characteristics and to the immune capabilities of the patients.